Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
PaperCitations, authors & open-access status
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,511 citations, 2012 year and green oa status.
1,511
Citations
2012
Year
green
OA Status